Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responses
Qiuhui Li, Qu Deng, Hsueh‐Ping Chao, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 123

Showing 1-25 of 123 citing articles:

Genomic and phenotypic heterogeneity in prostate cancer
Michael C. Haffner, Wilbert Zwart, Martine P. Roudier, et al.
Nature Reviews Urology (2020) Vol. 18, Iss. 2, pp. 79-92
Open Access | Times Cited: 359
ALDH1A1 drives prostate cancer metastases and radioresistance by interplay with AR- and RAR-dependent transcription
Ielizaveta Gorodetska, Anne Offermann, Jakob Püschel, et al.
Theranostics (2024) Vol. 14, Iss. 2, pp. 714-737
Open Access | Times Cited: 21
Cellular and Molecular Mechanisms Underlying Prostate Cancer Development: Therapeutic Implications
Ugo Testa, Germana Castelli, Elvira Pelosi
Medicines (2019) Vol. 6, Iss. 3, pp. 82-82
Open Access | Times Cited: 116
Intron retention is a hallmark and spliceosome represents a therapeutic vulnerability in aggressive prostate cancer
Dingxiao Zhang, Qiang Hu, Xiaozhuo Liu, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 113
CDK7 Inhibition Suppresses Castration-Resistant Prostate Cancer through MED1 Inactivation
Reyaz ur Rasool, Ramakrishnan Natesan, Qu Deng, et al.
Cancer Discovery (2019) Vol. 9, Iss. 11, pp. 1538-1555
Open Access | Times Cited: 109
Development and prevalence of castration-resistant prostate cancer subtypes
Jordan E. Vellky, William A. Ricke
Neoplasia (2020) Vol. 22, Iss. 11, pp. 566-575
Open Access | Times Cited: 99
Influence of Androgens on Immunity to Self and Foreign: Effects on Immunity and Cancer
Isabel Ben‐Batalla, María Elena Vargas-Delgado, Gunhild von Amsberg, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 95
Androgen receptor (AR) heterogeneity in prostate cancer and therapy resistance
Anmbreen Jamroze, Gurkamal Chatta, Dean G. Tang
Cancer Letters (2021) Vol. 518, pp. 1-9
Open Access | Times Cited: 94
Therapy-induced lipid uptake and remodeling underpin ferroptosis hypersensitivity in prostate cancer
Kaylyn D. Tousignant, Anja Rockstroh, Berwyck L. J. Poad, et al.
Cancer & Metabolism (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 90
Slow-cycling (dormant) cancer cells in therapy resistance, cancer relapse and metastasis
Sukanya Basu, Dong Yang, Rahul Kumar, et al.
Seminars in Cancer Biology (2021) Vol. 78, pp. 90-103
Open Access | Times Cited: 87
Targeting Bcl-2 for cancer therapy
Linlin Zhang, Zaiming Lu, Xiangxuan Zhao
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1876, Iss. 1, pp. 188569-188569
Closed Access | Times Cited: 86
Mechanisms of enzalutamide resistance in castration‐resistant prostate cancer and therapeutic strategies to overcome it
Yuanyuan Wang, Jiyuan Chen, Zhengjie Wu, et al.
British Journal of Pharmacology (2020) Vol. 178, Iss. 2, pp. 239-261
Open Access | Times Cited: 83
LIN28B promotes the development of neuroendocrine prostate cancer
Jessica M. Lovnicki, Yu Gan, Tingting Feng, et al.
Journal of Clinical Investigation (2020) Vol. 130, Iss. 10, pp. 5338-5348
Open Access | Times Cited: 78
A noncanonical AR addiction drives enzalutamide resistance in prostate cancer
Yundong He, Ting Wei, Zhenqing Ye, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 73
Understanding and targeting prostate cancer cell heterogeneity and plasticity
Dean G. Tang
Seminars in Cancer Biology (2021) Vol. 82, pp. 68-93
Open Access | Times Cited: 61
MiR-205-driven downregulation of cholesterol biosynthesis through SQLE-inhibition identifies therapeutic vulnerability in aggressive prostate cancer
Charis Kalogirou, Johannes Linxweiler, Philipp Schmucker, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 59
ARID1A loss induces polymorphonuclear myeloid-derived suppressor cell chemotaxis and promotes prostate cancer progression
Ni Li, Qiuli Liu, Ying Han, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 57
BET Bromodomain Inhibition Blocks an AR-Repressed, E2F1-Activated Treatment-Emergent Neuroendocrine Prostate Cancer Lineage Plasticity Program
Dae‐Hwan Kim, Duanchen Sun, William K. Storck, et al.
Clinical Cancer Research (2021) Vol. 27, Iss. 17, pp. 4923-4936
Open Access | Times Cited: 56
The Molecular Basis and Clinical Consequences of Chronic Inflammation in Prostatic Diseases: Prostatitis, Benign Prostatic Hyperplasia, and Prostate Cancer
Saheed Oluwasina Oseni, Corey Naar, Mirjana Pavlović, et al.
Cancers (2023) Vol. 15, Iss. 12, pp. 3110-3110
Open Access | Times Cited: 27
STAT3/LKB1 controls metastatic prostate cancer by regulating mTORC1/CREB pathway
Jan Pěnčík, C. Philippe, Michaela Schlederer, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 26
Androgen deprivation induces double-null prostate cancer via aberrant nuclear export and ribosomal biogenesis through HGF and Wnt activation
Won Kyung Kim, Alyssa J. Buckley, Donghoon Lee, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 11
Androgen and Androgen Receptors as Regulators of Monocyte and Macrophage Biology in the Healthy and Diseased Lung
Mireya Becerra-Díaz, Mason Song, Nicola Heller
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 63
NF-κB signaling promotes castration-resistant prostate cancer initiation and progression
Shayna E. Thomas‐Jardin, Haley Dahl, Afshan F. Nawas, et al.
Pharmacology & Therapeutics (2020) Vol. 211, pp. 107538-107538
Closed Access | Times Cited: 59
The Spatial and Genomic Hierarchy of Tumor Ecosystems Revealed by Single-Cell Technologies
Eric A. Smith, H. Courtney Hodges
Trends in cancer (2019) Vol. 5, Iss. 7, pp. 411-425
Open Access | Times Cited: 56
A glutaminase isoform switch drives therapeutic resistance and disease progression of prostate cancer
Lingfan Xu, Yu Yin, Yanjing Li, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 13
Open Access | Times Cited: 51
Page 1 - Next Page

Scroll to top